Improving human papilloma virus vaccination rates throughout military treatment facilities

被引:5
|
作者
Dawson, Rachel [1 ]
Lemmon, Keith [2 ]
Trivedi, Nidhi J. [3 ]
Hansen, Shana [4 ]
机构
[1] Baylor Scott & White Hlth, McLanes Childrens Hosp, 1901 SW HK Dodgen Loop, Temple, TX 76502 USA
[2] Madigan Army Med Ctr, 9040 Jackson Ave, Tacoma, WA 98431 USA
[3] Chicago Sch Profess Psychol, 325 N Wells, Chicago, IL 60654 USA
[4] San Antonio Mil Med Ctr, 3551 Roger Brooke Dr, Ft Sam Houston, TX 78234 USA
关键词
Adolescents; Human papilloma virus; Quality improvement; Vaccination; AGED; 13-17; YEARS; CARE PROVIDER RECOMMENDATION; NATIONAL IMMUNIZATION SURVEY; UNITED-STATES; HPV VACCINE; ADOLESCENTS; COVERAGE; HEALTH; INITIATION; WOMEN;
D O I
10.1016/j.vaccine.2018.02.007
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objectives: The four objectives of this study were to (1) educate military healthcare providers on HPV disease and vaccine, (2) assess short term recall of information presented at educational sessions, (3) assess provider comfort level with the vaccine, and (4) assess improvement in HPV vaccination rates. Methods: Standardized interactive educational sessions were conducted at military primary care clinics with pre- and post-educational quizzes administered before and immediately following the sessions. Provider attitudes were assessed using Likert scale questionnaires. Vaccination rates in children and young adolescents ages 11-18 at one of the participating regions that had a champion and started a Quality Improvement (QI) project were assessed at baseline, at 3-months and at 6-months post sessions. Results: 200 providers were reached at 48 primary care clinics during May 2014 through October 2015 with 200 quizzes and Likert scale questionnaires returned. There was increase in knowledge following the educational sessions as revealed in the pre- and post- test scores [t(57) = -5.04, p < 0.001]. There was a significant overall increase in comfort in answering patients' and parents' questions about HPV vaccine [p = 0.003]. There was a significant increase in the number of vaccines given at all the clinics 3-months after the educational sessions at the region who had a champion dedicated to monitoring vaccine rates and ensuring implementation efforts [p = 0.01] and started a QI project. This increase was not sustained at 6-months [p = 0.324]. Conclusions: Improvement in provider short term knowledge recall and comfort level in answering parents' questions was seen. We found that educational sessions can improve HPV vaccination rates in military clinics that have a vaccine champion for up to 3-months. Further research into the effects of having clinic vaccine champions is critical. (C) 2018 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1361 / 1367
页数:7
相关论文
共 50 条
  • [31] EARLY CERVICAL MYELITIS AFTER HUMAN PAPILLOMA VIRUS VACCINATION
    Fernandez-Fournier, Mireya
    de Teran, Javier Diaz
    Barranco, Antonio Tallon
    Puertas, Inmaculada
    NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2014, 1 (03):
  • [32] Human papilloma virus vaccination: perceptions of young Korean women
    Kang, Hee Sun
    Shin, Hyunsook
    Hyun, Myung-Sun
    Kim, Mi Ja
    JOURNAL OF ADVANCED NURSING, 2010, 66 (09) : 1946 - 1952
  • [33] HEALTH CARE PROFESSIONALS' ATTITUDE TO HUMAN PAPILLOMA VIRUS VACCINATION
    Cheung, M.
    Fonseca-Kelly, Z.
    O'Brien, S.
    Cosgrave, E.
    McSharry, E.
    Smith, O.
    Windrim, C.
    O'Brien, M.
    Treacy, T.
    Brennan, D.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 : 465 - 465
  • [34] 10 MINUTE CONSULTATION Discussing human papilloma virus vaccination
    Quah, Yan Ling
    Aggarwal, Ieera Madan
    BMJ-BRITISH MEDICAL JOURNAL, 2017, 357
  • [35] Ethical considerations of universal vaccination against human papilloma virus
    Pedro Navarro-Illana
    Justo Aznar
    Javier Díez-Domingo
    BMC Medical Ethics, 15
  • [36] Ethical considerations of universal vaccination against human papilloma virus
    Navarro-Illana, Pedro
    Aznar, Justo
    Diez-Domingo, Javier
    BMC MEDICAL ETHICS, 2014, 15
  • [37] Predictors Associated with the Willingness to Take Human Papilloma Virus Vaccination
    Cho Naing
    Joanne Pereira
    Tatsuki Abe
    Daniel Eh Zhen Wei
    Ibrizah Binti Abdul Rahman Bajera
    Undugodage Heshan Kavinda Perera
    Journal of Community Health, 2012, 37 : 288 - 293
  • [38] Cost-effectiveness of human papilloma virus vaccination in Iceland
    Oddsson, Kristjan
    Johannsson, Jakob
    Asgeirsdottir, Tinna Laufey
    Gudnason, Thorolfur
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2009, 88 (12) : 1411 - 1416
  • [39] Factors associated with Human papilloma virus (HPV) vaccination compliance
    Qureshi, Nadia K.
    Malhotra, Priya
    Ros, Sara
    Mani, Lisa
    Bello, Sofia
    Shahid, Ramzan
    PEDIATRICS, 2018, 142
  • [40] Vaccination against human papilloma virus in men: situation and proposals
    Cortes, Javier
    Gil, Angel
    Martinon, Federico
    Xavier Bosch, Francisco
    y Cajal, Jose Manuel Ramon
    MEDICINA BALEAR, 2022, 37 (03): : 166 - 170